1. Home
  2. ARVN vs FPI Comparison

ARVN vs FPI Comparison

Compare ARVN & FPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arvinas Inc.

ARVN

Arvinas Inc.

HOLD

Current Price

$8.10

Market Cap

516.2M

Sector

Health Care

ML Signal

HOLD

Logo Farmland Partners Inc.

FPI

Farmland Partners Inc.

HOLD

Current Price

$9.68

Market Cap

503.5M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARVN
FPI
Founded
2015
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
516.2M
503.5M
IPO Year
2018
2013

Fundamental Metrics

Financial Performance
Metric
ARVN
FPI
Price
$8.10
$9.68
Analyst Decision
Buy
Hold
Analyst Count
19
1
Target Price
$15.05
N/A
AVG Volume (30 Days)
685.8K
466.4K
Earning Date
05-04-2026
04-29-2026
Dividend Yield
N/A
3.14%
EPS Growth
58.84
N/A
EPS
N/A
0.01
Revenue
$262,600,000.00
$52,178,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$985.00
Revenue Growth
N/A
N/A
52 Week Low
$6.06
$9.37
52 Week High
$14.22
$13.23

Technical Indicators

Market Signals
Indicator
ARVN
FPI
Relative Strength Index (RSI) 46.57 45.92
Support Level N/A $9.45
Resistance Level $8.90 $10.59
Average True Range (ATR) 0.38 0.17
MACD 0.01 0.04
Stochastic Oscillator 22.00 46.93

Price Performance

Historical Comparison
ARVN
FPI

About ARVN Arvinas Inc.

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.

About FPI Farmland Partners Inc.

Farmland Partners Inc owns and seeks to acquire high-quality farmland throughout North America. The company is an internally managed real estate company which owns and contracts farmland and storage facilities located across the United States. Majority of the properties in its portfolio are used to grow primary crops, such as corn, soybeans, wheat, rice and cotton, and rest to produce specialty crops, such as almonds, pictachios, citrus, avacados, strawberies, and edible beans. The company generates its revenues through the rent it receives from its tenants.

Share on Social Networks: